JesMaimaris

Genomics, Immunology, Paediatrics, Rare Diseases. NIHR Clinical Lecturer @iit_ucl Burns/Morris Lab. Clinical Fellow on Topol Review

[JesMaimaris @JMaimaris]

In time for #RareDiseaseDay, the new GeNotes Immunology collection supports clinicians on when – and how – to access genomic testing for their patients. https://t.co/ng39bIBUBn

[JesMaimaris @JMaimaris]

@HBSMoLangs Happy Birthday!! 🎂 🎈

[JesMaimaris @JMaimaris]

Growing evidence of multiple kindreds described in international collaboration including ours in https://t.co/uMJlS052Qc @LondonAllergy @allergytom @broughallergy @Primary_Immune

[JesMaimaris @JMaimaris]

Our paper describing STAT6 GoF is finally out! We first came across this in 2018! Many thanks to our team @adrialb @ecmorris @Siobhan13592648 and many others not on Twitter @iit_ucl @uclmedsci This adds to growing evidence for role of STAT6 & #IEI in early-onset severe allergy

[Casanova Lab @casanova_lab]

Here is another beautiful report of STAT6 GOF underlying atopy:
Autosomal Dominant STAT6 Gain of Function Causes Severe Atopy Associated with Lymphoma https://t.co/6TOiNhWSxA

[Jen Heemstra @jenheemstra]

If you are working to chip away at a toxic culture to create a more positive future, that existing culture is likely going to chip away at you.

Finding a group of people where you can put each other back together again is invaluable.

[JesMaimaris @JMaimaris]

@TolarLab Many congratulations Doc! PhDone! 🤩

[JesMaimaris @JMaimaris]

@adrialb Fantastic work looking at functional validation of known and novel STAT1 GoFs! #STAT1 #PrimaryImmunodeficiency

[Adriana Albuquerque @adrialb]

Excited to share that our new study describing 5 new variants of unknown significance in the STAT1 gene is out. #PID #PrimaryImmunodefiency #STAT1 #RareDiseases

Practical challenges for functional validation of STAT1 gain of function genetic variants https://t.co/0Ja5LFHzx1

[JesMaimaris @JMaimaris]

@DrEmilyShaw @BennyChain @mnoursad @innate2adaptive @UCLInfectImm @Leo1401j Congratulations!!🥳

[JesMaimaris @JMaimaris]

@willberms Really great talks and was fab to see everyone again! Thanks for a great meeting #ukpin2021 #miga

[Prof Liz B 🇬🇧🇮🇱🇺🇦🇵🇸 @kidneydoc101]

#COVID19 #IndianVariant⬆️⬆️ in UK. Many #immunosuppressed #patients not immune after 2 doses #CovidVaccine. @CMO_England Urgently need:
a) allow 3rd dose;
b) shielding advice;
c)vaccinate all >18 & prob all >16
d)access to Mabs for non responders
@nadhimzahawi @kidneycareuk

[JesMaimaris @JMaimaris]

@grow_n22 @willmaimaris @EnjoyWoodGreen @ChoralLinnets @ecoexistUK @Duke_Nuke @haringeycouncil Great job @grow_n22 library garden also looking cheery in the spring 🌱 🌸 #grow_n22 #haringey #communitygarden

[Nick Schindler @DrNickTwit]

Twitter, I commend this thread to you.

[Viki Male @VikiLovesFACS]

Did you know that now 20,000 #pregnant people have had the #COVID19 #vaccine in the US? 🤰🏽

So of course, I have updated my explainer!

But how does the US safety data look so far? And how's it looking in the UK? 🧵

https://t.co/Aw0S36nD2a

[NHS North Central London ICB – Haringey @HaringeyNCLICB]

📢All #Haringey residents are invited to attend @haringeycouncil 's webinar about the COVID-19 vaccine on Tuesday 23 February at 7pm.

You can join the event on the night via this link: https://t.co/cJj8XY8LV4

[Nussenzweig_LAB @NussenzweigL]

We find that just like B cells, T follicular helper (TFH) cells undergo antigen-dependent clonal selection in germinal centres (GC) too - check out our work in @nature with work from @merkenschlagerj @FinkinS1 and many more https://t.co/HraxKC4yux

[Sethina Watson @morefluids]

I'm an NHS consultant anaesthetist. I see the terror in my Covid patients' eyes

Brilliant piece of writing. https://t.co/6gdriQp36h

[Barbara Kee @BarbaraLKee]

A 2020 View of Thymus Stromal Cells in T Cell Development https://t.co/GhjTgZA8vX

[JesMaimaris @JMaimaris]

Good explanation regarding the nuances and need to be pragmatic

[Eric Topol @EricTopol]

Immunocompromised patients "may shed viable [replication competent, grown in culture] #SARSCoV2 for at least 2 months." Results from 20 patients w/ #cancer who received stem cell transplants or CAR T-cells @NEJM https://t.co/Ll4QNKZ3t3